Effect of a 15-day Memantine Treatment on Biomarkers of AD in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 14 Nov 2017
At a glance
- Drugs Memantine (Primary)
- Indications Alzheimer's disease
- Focus Biomarker; Pharmacodynamics
- 08 Nov 2017 Planned End Date changed from 1 Feb 2018 to 1 Feb 2019.
- 08 Nov 2017 Planned primary completion date changed from 1 Jan 2018 to 1 Jan 2019.
- 25 Oct 2016 Status changed from not yet recruiting to recruiting.